- Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge (bloomberg.com)
Gilead Sciences, maker of the hepatitis C drugs Sovaldi and Harvoni, posted second-quarter profit that topped analysts’ estimates as revenue surged. Gilead raised its sales forecast for the year.
- GAO IDs 3 ways DEA can improve communications with pharmacists, manufacturers (drugstorenews.com)PRESCRIPTION DRUGS More DEA Information about Registrants Controlled Substances Roles Could Improve Their Understanding and Help Ensure Access (gao.gov)
lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines, according to a report released by…Government Accountability Office…Both distributors and retail pharmacies still request improved guidance and a greater degree of interaction with the DEA, though the agency does not concur,…
- Civil Penalty Settlement Reached with CVS Pharmacy in Car (dea.gov)
civil settlement with CVS Health in connection with allegations that the CVS pharmacy in Carver (Boston area) violated federal regulations related to the sale of prescription drugs… armed robbers stole large quantities of Schedule II prescription drugs.. CVS reported one of the thefts immediately but waited three weeks to report the other one…investigators found… discrepancies… to keep complete and accurate records of its controlled substances..
- Experimental MERS vaccine shows promise in animal studies (newsdaily.com)
Researchers…trying to develop a vaccine against the deadly Middle East Respiratory Syndrome (MERS) virus say they have had early signs of success in animal experiments.
- Health Spending to Gobble Up More of U.S. Economy in Next Decade (bloomberg.com)
Spending on health care will take up an increasing proportion of the U.S. economy over the next decade as the population ages and more people gain insurance coverage under Obamacare,…Payments for hospitals, doctors, drugs and insurance will rise by about 5.8 percent a year through 2024, 1.1 percentage points faster than overall economic growth,...
- Drug maker tied to Vegas hepatitis outbreak to buy Allergan unit for $40.5B (reviewjournal.com)
Teva… linked to the 2008 hepatitis C outbreak in Las Vegas, has agreed to buy Allergan … generic drugs business… will turn (Teva ) into one of the world's largest pharmaceutical firms… In..2012, Teva… agreed to pay $285 million to settle…lawsuits arising from the hepatitis C outbreak tied to the Endoscopy Center of Southern Nevada.. Teva and Baxter Healthcare…were found liable..
- DEA Announces 10th National Prescription Drug Take-Back (dea.gov)
10th National Prescription Drug Take-Back will take place September 26th from 10 am-2 pm local time in every state…. sites will be set up throughout communities nationwide so local residents can return their unwanted, unneeded, or expired prescription drugs for safe disposal...
- Pharma’s Bright Future: Meet The Top 10 Drugs of 2020 (drugchannels.net)
latest edition of EvaluatePharma’s World Preview 2015, Outlook to 2020. This annual report projects for prescription drug sales and R&D activity in the U.S. and abroad…THINGS ARE GOING GREAT……AND THEY'RE ONLY GETTING BETTER..
- Marijuana dispensary considers lawsuit over delayed opening (reviewjournal.com)
Frustrated by what they call arbitrary actions by Clark County officials that have delayed their opening, the owners of a medical marijuana dispensary (Euphoria Wellness) are considering legal action…. it has not been able to get enough marijuana to sell… Other issues, including the state’s pesticide rules, also have contributed to delays..
- Pfizer’s revenue, profit beat as vaccine sales rise (newsdaily.com)
Pfizer….reported better-than-expected second-quarter profit and revenue, helped by strong demand for its pneumonia vaccine (Prevnar ) and new breast cancer drug (Ibrance), sending its shares up 1 percent…. global vaccines unit rose 44 percent to $1.58 billion… breast cancer drug ...generated $140 million in sales in its first full quarter on the market..